Saturday 17 October 2026 Export ZVRA’s income statement to Excel — free account

Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $106.5 million, up 350.9% from fiscal 2024. In the quarter to June 2026, revenue grew 53.3%, EPS fell 88.7%, free cash flow grew 670.9% and total debt rose 4.07%, each against the same quarter a year earlier.

9.95 0.32 −3.12%

Follow ZVRA

Alert me

Market cap: $609.9M
P/E: 10.5×
Fwd P/E: 10.5×
Dividend yield: —
F-score: 6/9
Altman Z: 0.63
Beneish M: 1.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	15.09	4.55	6.54	19.02	+8 more quarters Free account
P/S ratio Full definition →	6.23	4.45	4.65	6.31
P/FCF ratio Full definition →	25.65	43.60	0.00	0.00
P/Operating CF Full definition →	49.81	88.63	89.85	113.00
P/B ratio Full definition →	3.90	2.65	3.20	4.00
Price to Tangible BV Full definition →	4.09	2.79	3.45	4.37
EV/Sales Full definition →	5.34	3.63	3.80	5.11
EV/EBITDA Full definition →	9.01	8.43	0.00	0.00
EV/Operating CF Full definition →	21.75	34.73	(252.94)	(18.47)
EV/FCF Full definition →	21.96	35.51	(203.63)	(18.20)
Quick Ratio Full definition →	5.02	4.74	5.46	8.29
Current Ratio Full definition →	5.17	4.89	5.68	8.62
Net Debt/EBITDA Full definition →	(13.39)	(3.87)	(14.64)	(41.58)
Debt/Assets Full definition →	0.00%	0.00%	21.75%	22.70%
Debt/Equity Full definition →	0.00	0.00	0.40	0.46
Asset Turnover Full definition →	0.49	0.54	0.46	0.37
Operating CF/Net income Full definition →	2.03	0.17	0.41	(8.66)
Capex/Depreciation Full definition →	(20.52)	(171.65)	0.22	(0.04)
Interest Coverage Full definition →	—	30.48	4.78	2.02
Research and Development Expense of Revenue Full definition →	11.31%	12.13%	7.68%	13.17%
Selling, General and Administrative Expense of Revenue Full definition →	41.75%	57.38%	59.65%	64.98%
Intangible Assets out of Total Assets Full definition →	0.03	0.04	0.04	0.04
Share Based Compensation of Revenue Full definition →	7.49%	8.57%	12.55%	10.63%
Graham Net Nets Full definition →	0.20	0.29	0.19	0.17
Graham Number Full definition →	8.87	12.75	9.28	5.17
Earnings Yield Full definition →	6.62%	22.00%	15.29%	5.26%
Free Cash Flow Yield Full definition →	3.90%	2.29%	(0.40%)	(4.46%)
Revenue per Share Full definition →	0.67	0.62	0.62	0.47
Operating CF per Share Full definition →	0.29	0.11	0.10	0.08
Capex per Share Full definition →	0.08	0.75	0.00	0.00
Free Cash Flow per Share Full definition →	0.37	0.86	0.10	0.08
Cash per Share Full definition →	3.75	3.43	3.45	3.57
Shareholders Equity per Share Full definition →	3.68	3.52	2.80	2.38
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	3.68	3.52	2.80	2.38
Free Cash Flow Full definition →	21.77	50.08	5.41	4.74
Working Capital Full definition →	202.67	182.94	183.73	199.00
Capital Expenditures Full definition →	4.74	43.94	(0.11)	0.04
Net Current Asset Value Full definition →	166.24	157.19	92.93	88.16
EV/EBIT Full definition →	8.82	0.00	0.00	0.00
Capex to Sales Full definition →	(0.12)	(1.21)	0.00	0.00
Price to Operating Income Full definition →	10.30	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	20.38	17.36	16.88	12.32
Average Payables Full definition →	14.90	14.75	18.53	17.77
Average Inventory Full definition →	1.78	2.43	1.86	—
Average Assets Full definition →	279.49	225.64	231.43	230.83
Average Common Equity Full definition →	167.44	123.41	97.16	101.47

Show all line items

Columns are period end dates

Stockrow Weekly